Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Leukemia, Myeloid, Acute 69Myelodysplastic Syndromes 26Leukemia, Myelomonocytic, Chronic 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Leukemia 6Leukemia, Biphenotypic, Acute 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Monocytic, Acute 4Hematologic Neoplasms 4Primary Myelofibrosis 3Leukemia, Myelomonocytic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Thrombocythemia, Essential 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Strabismus 1Small Cell Lung Carcinoma 1Skin Neoplasms 1

Interventions

Methylphenidate 2Methods 2sargramostim 1ropidoxuridine 1entrectinib 1entinostat 1cc-486 1carboxyamido-triazole 1bintrafusp alfa protein, human 1Watchful Waiting 1WP 744 1Vincristine 1Thalidomide 1Temozolomide 1Ritonavir 1Radiotherapy 1Quality of Life 1Psychology, Positive 1Psychiatric Rehabilitation 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1O(6)-benzylguanine 1N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide 1Molecular Diagnostic Techniques 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Injections × Other hematologic neoplasm × Clear all
NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Celgene

Phase 1 Completed
89 enrolled
BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡